12/21
Headlines

VSAR

Small Cap Decliners: Vital Therapies (NASDAQ:VTL), China Biologic Products (NASDAQ:CBPO), Versartis (NASDAQ:VSAR), Theravance (NASDAQ:TBPH), VASCO Data Security International(NASDAQ:VDSI)

Kevin Long02 mins

Vital Therapies currently has a Zacks Rank #3 (Hold). Vital Therapies Inc (NASDAQ:VTL) stock performance was -5.83% in last session and finished the day at $30.52. Traded volume was 94.00K shares in the last session and the average volume of the stock remained 96.31K shares. China Biologic Products (CBPO) shares fell in late trading after…

Read More

Healthcare Gainers: Health Insurance Innovations Inc (NASDAQ:HIIQ), Biostar Pharmaceuticals (NASDAQ:BSPM), Applied Genetic Technologies (NASDAQ:AGTC), Versartis Inc (NASDAQ:VSAR), Sorrento Therapeutics (NASDAQ:SRNE)

John Bellich03 mins

Research analysts at Dougherty & Co assumed coverage on shares of Health Insurance Innovations Inc (NASDAQ:HIIQ) in a report released on Friday, TheFlyOnTheWall.com reports. The firm set a “buy” rating on the stock. Health Insurance Innovations Inc (NASDAQ:HIIQ) stock performance was 5.89% in last session and finished the day at $10.43. Traded volume was 30,114.00million…

Read More

Stocks Touched New Highs: Applied Genetic Technologies Corp (NASDAQ:AGTC), Versartis Inc (NASDAQ:VSAR), Orthofix International NV (NASDAQ:OFIX), Alder Biopharmaceuticals Inc (NASDAQ:ALDR), Enzo Biochem, Inc. (NYSE:ENZ)

Kevin Long03 mins

Applied Genetic Technologies Corp (NASDAQ:AGTC) had its price target increased by BMO Capital Markets from $21.00 to $34.00 in a research report sent to investors on Monday morning. The firm currently has an outperform rating on the stock. Applied Genetic Technologies Corp (NASDAQ:AGTC) stock performance was 6.26% in last session and finished the day at…

Read More

Healthcare Stocks Touched New Lows: VIVUS (NASDAQ:VVUS), Akebia Therapeutics Inc (NASDAQ:AKBA), Versartis Inc (NASDAQ:VSAR), BioLife Solutions (NASDAQ:BLFS)

Kristen Barton02 mins

VIVUS Inc. (NASDAQ:VVUS) lower following news late Tuesday night that three directors — J. Martin Carroll, Mark B. Logan and Robert N. Wilson — will not stand for re-election to the company’s Board. This will be the sixth-straight session for the stock to close lower. VIVUS, Inc. (NASDAQ:VVUS) stock performance was 0.20% in last session…

Read More